A new study by researchers in the Department of Clinical Neuroscience, Karolinska Institutet, has identified 18 potential ...

When ocrelizumab became the first FDA-approved treatment for early forms of multiple sclerosis (MS) in 2017, it offered ...

A trial using PET scans to test the anti-inflammatory drug PIPE-791 finished enrolling healthy volunteers and patients with ...

UC Riverside study may lead to new treatments for multiple sclerosis. Multiple sclerosis (MS) affects an estimated 2.3 ...

A new low-cost generic form of Tecfidera is available in the U.S. for people with relapsing forms of MS for a fraction of the ...

The new drug called Lleniolisib (Joenja) is a simple tablet taken twice a day and is the first ever targeted treatment for ...

The substance has been found in heroin, cannabis, and black market pills sold as the anti-anxiety drug diazepam ...

Australia’s newest investigative journalism program has kicked off with a bombshell program presenting evidence it claims can ...

TG Therapeutics, Inc.'s BRIUMVI saw Q1 2025 revenue surge 137% YoY. Click to learn about TGTX growth, upcoming trials, and ...

Learn how Bruker’s latest innovations are enhancing small molecule analysis for toxicology and environmental analysis.